Simtomax® has obtained TGA registration, allowing for commercialization in Australia
4 May 2014
Augurix and HealthScreenSolutions Pty Ltd are pleased to announce that Simtomax®, a rapid point-of-care diagnostic test for celiac disease, has been registered by the Australian Therapeutics Goods Administration (TGA).
Augurix and HealthScreenSolutions had entered into a commercialization agreement for Simtomax®, providing HealthScreenSolutions with the exclusive right to distribute and supply Simtomax® in Australia and New Zealand.
Get the PressRelease